NCT06771076

Brief Summary

There is a high prevalence of chronic pain in our society, which is detrimental at an individual and country level. Cannabidiol (CBD) has been proposed as a promising treatment for chronic pain, although more high-quality studies are needed in this area. On the other hand, triathlon, running, cycling, and swimming are sports modalities that have an increasing professionalism and importance, albeit not exempt from injuries. The main goal of this study is to assess the effectiveness of a topical treatment for recurrent chronic pain caused by tendinopathies with a cream containing CBD in triathletes, runners, cyclists, and swimmers. Consequently, the research question for this study is the following: Can the CBD cream be effective in treating chronic pain? The investigators hypothesize that the cream will be able to affect the pain, both in the short and the long term. The study will be interventional, with a crossover, randomized, and double-blinded design. Two groups of participants will be generated, as well as two treatment options (CBD cream, and a similar one without the CBD). The subjects will apply one of the treatments for one month, followed by a wash-out week without any cream application, and another month with the other treatment. During these weeks, different parameters will be controlled via online questionnaires. The analyzed variables will include the following: Chronic pain, acute pain, wellness, perceived exertion, quality of life, and satisfaction with the treatment. Different statistical tests will be applied to the collected data, comparing their means and correlations to infer the results.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 19, 2024

Completed
25 days until next milestone

First Posted

Study publicly available on registry

January 13, 2025

Completed
5 days until next milestone

Study Start

First participant enrolled

January 18, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 16, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 16, 2025

Completed
Last Updated

May 28, 2025

Status Verified

May 1, 2025

Enrollment Period

4 months

First QC Date

December 19, 2024

Last Update Submit

May 21, 2025

Conditions

Keywords

CBDCannabidiolTriathlonChronic injuriesRunningCyclingSwimming

Outcome Measures

Primary Outcomes (2)

  • Chronic effect of the cream

    Assessment of the pain in the affected zone/s. The measurement will be done once per week (Fridays at night). Assessed using the Oslo Sports Trauma Research Center Overuse Injury Questionnaire (metric: answers to the questions of the instrument).

    Through the two 1-month intervention periods.

  • Acute effect of the cream

    Assessment of the pain in the affected zone/s. The measurement will be done twice per day before applying the cream (after waking up and before going to bed). Besides, the first time the creams are used, the questionnaire will be answered after 5, 10, 15, and 30 minutes. Assessed using a Visual Analog Scale (metric: answer to the question of the instrument). This scale is answered by moving a slider through a line until the desired number is reached, ranging from 0 to 10. Higher scores mean more pain (a worse outcome).

    Through the two 1-month intervention periods.

Secondary Outcomes (4)

  • Effect of the cream on wellness

    Through the two 1-month intervention periods.

  • Effect of the cream on the perceived exertion

    Through the two 1-month intervention periods.

  • Effect of the cream on the quality of life

    After the two 1-month intervention periods.

  • Treatment assessment

    After the two 1-month intervention periods.

Study Arms (2)

Cream with CBD and natural ingredients - Cream without CBD and natural ingredients

EXPERIMENTAL

During the first month participants will use the cream with CBD and natural ingredients, and during the second month, the cream without CBD and natural ingredients.

Other: Cream with CBD and natural ingredientsOther: Cream without CBD and natural ingredients

Cream without CBD and natural ingredients - Cream with CBD and natural ingredients

EXPERIMENTAL

During the first month participants will use the cream without CBD and natural ingredients, and during the second month, the cream with CBD and natural ingredients.

Other: Cream with CBD and natural ingredientsOther: Cream without CBD and natural ingredients

Interventions

Topical application of the cream with CBD and natural ingredients on the injured areas, twice per day (after waking up, and before going to bed). A crossover with the other intervention will be done in the next/previous month (depending on the arm).

Also known as: Cream with CBD
Cream with CBD and natural ingredients - Cream without CBD and natural ingredientsCream without CBD and natural ingredients - Cream with CBD and natural ingredients

Topical application of the cream without CBD and natural ingredients on the injured areas, twice per day (after waking up and before going to bed). A crossover with the other intervention will be done in the next/previous month (depending on the arm).

Also known as: Cream without CBD
Cream with CBD and natural ingredients - Cream without CBD and natural ingredientsCream without CBD and natural ingredients - Cream with CBD and natural ingredients

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being a federated triathlete, runner, cyclist, or swimmer.
  • Being 18-70 years old.
  • Having chronic pain (present at least 3 months before the beginning of the study).
  • Having a diagnosis of patellar, Achilles, or iliotibial band tendinopathy for the lower extremities, and/or shoulder rotator cuff or biceps brachii tendinopathy for the upper extremities.
  • Training any modality of triathlon, running, cycling, or swimming 4-5 days per week with a minimal training volume of 8 hours per week.
  • Having at least 1 year of experience training in triathlon, running, cycling, or swimming.
  • Providing at least 80% of the needed data for the study.

You may not qualify if:

  • Pregnant women.
  • People allergic to any of the ingredients of the creams used.
  • People with skin injuries in the zones in which the cream has to be applied.
  • Using any other pain treatments. Those who use them before the study can still participate if they stop their usage 1 week before the beginning of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Vic - Central University of Catalonia

Vic, Barcelona, 08500, Spain

Location

Related Publications (5)

  • Clarsen B, Bahr R, Myklebust G, Andersson SH, Docking SI, Drew M, Finch CF, Fortington LV, Haroy J, Khan KM, Moreau B, Moore IS, Moller M, Nabhan D, Nielsen RO, Pasanen K, Schwellnus M, Soligard T, Verhagen E. Improved reporting of overuse injuries and health problems in sport: an update of the Oslo Sport Trauma Research Center questionnaires. Br J Sports Med. 2020 Apr;54(7):390-396. doi: 10.1136/bjsports-2019-101337. Epub 2020 Feb 14.

    PMID: 32060142BACKGROUND
  • Delgado DA, Lambert BS, Boutris N, McCulloch PC, Robbins AB, Moreno MR, Harris JD. Validation of Digital Visual Analog Scale Pain Scoring With a Traditional Paper-based Visual Analog Scale in Adults. J Am Acad Orthop Surg Glob Res Rev. 2018 Mar 23;2(3):e088. doi: 10.5435/JAAOSGlobal-D-17-00088. eCollection 2018 Mar.

    PMID: 30211382BACKGROUND
  • McLean BD, Coutts AJ, Kelly V, McGuigan MR, Cormack SJ. Neuromuscular, endocrine, and perceptual fatigue responses during different length between-match microcycles in professional rugby league players. Int J Sports Physiol Perform. 2010 Sep;5(3):367-83. doi: 10.1123/ijspp.5.3.367.

    PMID: 20861526BACKGROUND
  • Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377-81.

    PMID: 7154893BACKGROUND
  • Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med. 1998 May;28(3):551-8. doi: 10.1017/s0033291798006667.

    PMID: 9626712BACKGROUND

MeSH Terms

Conditions

TendinopathyWounds and InjuriesChronic PainMotor Activity

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesTendon InjuriesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • Javier Peña López, Ph.D.

    Sport, Exercise, and Human Movement (SEaHM), University of Vic - Central University of Catalonia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Both creams will have identical containers (a neutral white tube), with the only difference being that they will be tagged with the letter "A" or "B" (without any additional information on any part of the container).
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Participants will have two periods of one month in which they will use different creams, one containing CBD and natural ingredients, while the other will not. The cream not used during the first month will be the used one in the second month. These periods will be separated by a one-week wash-out.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 19, 2024

First Posted

January 13, 2025

Study Start

January 18, 2025

Primary Completion

May 16, 2025

Study Completion

May 16, 2025

Last Updated

May 28, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations